Cell MedX Corp. (CMXC) financial statements (2021 and earlier)

Company profile

Business Address 123 W. NYE LN, SUITE 446
CARSON CITY, NV 89706
State of Incorp. NV
Fiscal Year End May 31
SIC 59 - Miscellaneous Retail (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments224557867281
Cash and cash equivalents224557867281
Inventory, net of allowances, customer advances and progress billings53527311851
Inventory53527311851
Prepaid expense      19
Other current assets216059262530 
Total current assets:96157189451006221
Noncurrent Assets
Property, plant and equipment221 19420726
Deposits noncurrent assets      26
Other undisclosed noncurrent assets      (26)
Total noncurrent assets:221 19420726
TOTAL ASSETS:981591914529426947
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities401943781620541422250
Accounts payable391909734595448384220
Accrued liabilities10352621803830
Interest and dividends payable  21413  
Debt  585117541  
Due to related parties734234384334343308206
Other undisclosed current liabilities   4738952274
Total current liabilities:1,1351,1771,7491,1191,4631,681731
Noncurrent Liabilities
Other undisclosed liabilities646502214    
Total liabilities:1,7811,6801,9631,1191,4631,681731
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,050)(1,887)(1,787)(1,073)(1,169)(1,413)(684)
Common stock5956444440  
Common stock, value, subscriptions 80     
Additional paid in capital6,3565,9885,1104,9163,2941,734325
Accumulated other comprehensive income (loss)(25)39163021
Accumulated deficit(8,440)(8,050)(6,957)(6,051)(4,504)(3,255)(1,115)
Other undisclosed stockholders' equity attributable to parent   14 106106
Other undisclosed stockholders' equity36636614    
Total stockholders' equity:(1,684)(1,520)(1,773)(1,073)(1,169)(1,413)(684)
TOTAL LIABILITIES AND EQUITY:981591914529426947

Income statement (P&L) ($ in thousands)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Revenues6996  63743
Revenue, net 63743
Cost of revenue(12)(10)  (4)(866)(293)
Cost of goods and services sold(1)(10)  (4)(28)(27)
Other undisclosed gross profit6    838266
Gross profit:6386  2816
Operating expenses(2,065)(1,124)670(1,536)(1,223)(1,246)(756)
Operating income (loss):(2,002)(1,038)670(1,536)(1,220)(1,238)(739)
Nonoperating income (expense)(137)(79)13217 (5)
Investment income, nonoperating    12  
Foreign currency transaction gain (loss), before tax(35)231324 (5)
Other nonoperating expense(102)(102)     
Interest and debt expense4448(219)(11)(6)(33)(6)
Income (loss) from continuing operations before income taxes:(2,095)(1,070)464(1,545)(1,210)(1,271)(750)
Income tax benefit 229190333425 351
Other undisclosed income from continuing operations229      
Income (loss) before gain (loss) on sale of properties:(1,865)(840)655(1,212)(785)(1,271)(399)
Other undisclosed net income (loss)1,456(252)(1,561)(335)(465)  
Net loss:(409)(1,093)(906)(1,547)(1,249)(1,271)(399)
Other undisclosed net loss attributable to parent(525)    (868)(633)
Net loss available to common stockholders, diluted:(934)(1,093)(906)(1,547)(1,249)(2,139)(1,032)

Comprehensive Income ($ in thousands)

11/30/2020
TTM
5/31/2020
5/31/2019
5/31/2018
5/31/2017
5/31/2016
5/31/2015
Net loss:(409)(1,093)(906)(1,547)(1,249)(1,271)(399)
Other comprehensive loss   (1,545)(1,251)  
Comprehensive loss:(409)(1,093)(906)(3,091)(2,500)(1,271)(399)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(560)2313  (867)(632)
Comprehensive loss, net of tax, attributable to parent:(969)(1,070)(893)(3,091)(2,500)(2,138)(1,031)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: